Clinical Trial: Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Multicenter, Double-Blind, Placebo-Controlled, Ascending-Dose, Repeat-Dose Safety and Pharmacokinetic Investigation of a Delayed-Release, Enteric-Coated Capsule Formulation of AVX 470 [Anti-TNF (Tum

Brief Summary: The purpose of this study is to evaluate the safety and tolerability as well as the pharmacodynamic effects of multiple doses of AVX-470 administered orally in patients with active ulcerative colitis.